Finance
Tapestry Pharmaceuticals reports Q4 2005 net loss from continuing operations of $3 million
Published in Biotech Business Week, March 20th, 2006
The net loss from continuing operations for the fourth quarter of 2005 was $3 million compared to a net loss from continuing operations of $5.3 million for the fourth quarter of 2004. The net loss for the fourth quarter of 2005 was $3 million, or 87 cents basic and diluted loss per share. This compares to a net loss for the fourth quarter of 2004 of $8 million, or $2.41 basic and diluted loss per share, which included a loss from discontinued operations of $2.7 million resulting from the exit of substantially all of our Genomics Division related...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
More Articles from Biotech Business Week
- Business Update
Pharmaceutical company mulling divestiture of Consumer Health Unit, market report says - Genetics & Genomics
BioInformatics study shows New England Biolabs leads restriction enzyme market - Market Analysis
E.U. admittance presents new opportunities in Eastern European medical devices markets - Market Analysis
Late-stage heart failure pipeline weak with 81% of products in development, report says - Market Analysis
New rheumatoid arthritis drugs may push biologics above traditional therapies, report says - Adverse Drug Reaction
Public health advisory for Trasylol issued by U.S. FDA - More from this issue of Biotech Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
